Feedback plc (AIM:FDBK)
11.15
0.00 (0.00%)
Feb 13, 2026, 8:00 AM GMT
Feedback Revenue
In the fiscal year ending May 31, 2025, Feedback had annual revenue of 885.62K GBP, down -25.05%. Feedback had revenue of 436.62K in the half year ending May 31, 2025, a decrease of -2.76%.
Revenue
885.62K
Revenue Growth
-25.05%
P/S Ratio
5.52
Revenue / Employee
30.54K
Employees
29
Market Cap
4.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 885.62K | -295.92K | -25.05% |
| May 31, 2024 | 1.18M | 156.55K | 15.27% |
| May 31, 2023 | 1.02M | 436.42K | 74.15% |
| May 31, 2022 | 588.58K | 301.16K | 104.78% |
| May 31, 2021 | 287.42K | -162.57K | -36.13% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Surgical Innovations Group | 11.92M |
| Cambridge Nutritional Sciences | 8.06M |
| Proteome Sciences | 4.53M |
| N4 Pharma | 7.07K |
Feedback News
- 1 year ago - Half Year 2025 Feedback PLC Investor Presentation Transcript - GuruFocus